Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. weekly average of COVID-19 cases and hospitalizations down 15%

Published 10/01/2021, 11:33 AM
Updated 10/01/2021, 12:51 PM
© Reuters. FILE PHOTO: Dr. Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention, testifies during a U.S. Senate Health, Education, Labor and Pensions Committee hearing on Capitol Hill in Washington, U.S., March 18, 2021. Susan Walsh/Poo

By Lisa Lambert, Ahmed Aboulenein and Jeff Mason

WASHINGTON (Reuters) -U.S. Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky on Friday said that weekly COVID-19 cases and hospitalizations in the United States were down 15% from the previous week.

The United States had a daily average of 106,400 COVID-19 cases, 8,300 hospitalizations and more than 1,476 deaths in its most recent seven-day period, Walensky told reporters at a White House briefing.

The U.S. is on track to double the number of COVID-19 rapid-scale tests on the market over the next 60 says, said White House coronavirus response coordinator Jeff Zients.

Health officials welcomed news that a pill developed by U.S. drugmaker Merck could halve the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, but would not provide a timeline for when it could be approved by regulators.

"The news of the efficacy of this particular antiviral is obviously very good news. The company when they briefed us last night, had mentioned that they will be submitting their data to the FDA imminently. The data are impressive," said Dr Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases.

Latest comments

Covid planned demic is over
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.